pull down to refresh

I have heard grim accusations of pharmaceutical companies or health insurers who have an incentive to keep people sick. It's one thing to profit from the eventuality, it's another to cause the eventuality that leads to profit. I have assumed that many of the anti prediction market arguments are the latter.

I'd argue that financial incentives within the medical industry do influence decision making towards hte more profitable outcomes.

It's not quite as far as saying they cause the medical problems, but it is going as far as to say their treatment decisions are influenced by the financial incentives, and that some of those treatment decisions may lead to worse outcomes for the patients.

I think it's also safe to assume the industry doesn't invest in finding unprofitably cheap cures.

reply